Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
(NASDAQ: VIR) Delayed: 9.57 +0.41 (4.48%)
Previous Close $9.16    52 Week High $ 
Open $9.29    52 Week Low $ 
Day High $9.63    P/E N/A 
Day Low $9.16    EPS $ 
Volume 1,793,539